Olmesartan Medoxomil / Hydrochlorothiazide Combination Tablets
(often sold as “Olmetec” or similar branded names)
What is it?
This tablet combines two active ingredients:
| Ingredient |
Drug class |
Primary action |
| Olmesartan medoxomil |
Angiotensin II receptor blocker (ARB) |
Blocks the angiotensin‑II type‑1 receptor → vasodilation, reduces aldosterone, lowers blood pressure. |
| Hydrochlorothiazide (HCTZ) |
Thiazide‑type diuretic |
Inhibits sodium‑chloride reabsorption in the distal tubule → increased sodium & water excretion → reduced plasma volume and pressure. |
The combination is used for hypertension (high blood pressure) that is not fully controlled with a single drug or where a dual mechanism is preferred.
How is it taken?
- Typical adult dose:
- 10 mg olmesartan + 12.5 mg HCTZ once daily (morning or evening).
- May be titrated up to 20 mg olmesartan + 25 mg HCTZ, depending on response and tolerability.
- Take with food or a full glass of water to help absorption and reduce stomach upset.
- Do not crush or chew the tablet – it’s designed to release slowly (extended‑release formulation).
How does it work together?
- Olmesartan reduces peripheral resistance and has a long action (≈24 h).
- Hydrochlorothiazide lowers volume early in the day, then the ARB maintains control over the next 24 h.
- The combo can achieve better BP lowering than either agent alone, especially in patients with resistant hypertension or those needing a diuretic.
Who should not take it?
| Category |
Reason |
| Pregnancy |
Both drugs are category D; avoid. |
| Severe renal impairment |
HCTZ is cleared by the kidneys; can worsen kidney function. |
| Hyperkalemia |
Olmesartan can raise potassium levels. |
| Hypotension |
May worsen low blood pressure. |
| Patients on potassium‑sparing diuretics |
Increased risk of hyperkalemia. |
| Active liver disease |
Limited data; use cautiously. |
If you have any of these conditions or are uncertain, discuss with your healthcare provider.
Common side effects
| Symptom |
Typical frequency |
| Dizziness, light‑headedness (especially first dose) |
5–10 % |
| Headache |
<5 % |
| Fatigue |
<5 % |
| Nasal congestion |
<5 % |
| Diarrhea or constipation |
<5 % |
| Hyperkalemia (elevated potassium) |
<1 % |
| Hypokalemia (due to HCTZ) |
<1 % |
| Increased urination |
Common |
Most side effects are mild and transient. If they persist or worsen, contact your prescriber.
Serious but rare risks
- Angioedema (especially with ARBs) – swelling of lips, tongue, or face; seek emergency care if it occurs.
- Severe hyperkalemia – muscle weakness, palpitations.
- Electrolyte imbalance (low sodium, potassium, magnesium) – especially in older adults or those on other diuretics.
- Renal impairment – monitor kidney function regularly.
- Low blood pressure – symptoms of fainting, especially after standing.
Drug interactions
| Drug |
Interaction |
What to watch for |
| Potassium‑sparing diuretics (e.g., spironolactone, triamterene) |
↑ potassium |
Hyperkalemia |
| Digoxin |
↑ serum levels |
Arrhythmias |
| NSAIDs (ibuprofen, naproxen) |
↓ diuretic effect, ↑ renal risk |
Reduced BP control, kidney injury |
| Other antihypertensors (beta‑blockers, ACE inhibitors) |
Additive BP lowering |
Hypotension |
| Lithium |
↑ lithium levels |
Neurotoxicity |
| Allopurinol |
↑ uric acid levels |
Gout flare |
| Statins |
↑ muscle injury risk |
Myopathy |
| Corticosteroids |
↑ potassium |
Hyperkalemia |
Always inform your pharmacist or prescriber of all medications you’re taking, including OTC drugs and supplements.
Lifestyle tips to maximize benefit
- Low‑sodium diet (≤ 1500 mg/day) enhances BP control.
- Regular exercise (≥ 150 min moderate aerobic activity per week).
- Limit alcohol and avoid binge drinking.
- Monitor blood pressure at home (twice daily) and keep a log.
- Stay hydrated but avoid excessive fluids if you have fluid overload risk.
- Adhere to scheduled dosing – missing doses can undermine control and increase risk of rebound hypertension.
When to seek medical attention
- Severe dizziness, fainting, or chest pain.
- Swelling of lips, tongue, face, or throat.
- Severe muscle pain or weakness.
- Persistent nausea, vomiting, or diarrhea.
- Signs of kidney problems (decreased urine output, swelling in legs).
- Any sudden changes in vision or hearing.
Key take‑away
Olmesartan/HCTZ combo tablets are a well‑established, effective first‑line or add‑on therapy for hypertension that leverages both vascular and diuretic mechanisms. When taken as directed and monitored for side effects and drug interactions, most patients achieve good blood‑pressure control with few problems.
If you have any questions about your specific dose, schedule, or how this medication fits with other drugs you’re using, feel free to ask or bring this information to your next appointment.